Delivery Order SPE2D021D0004-SPE2D024F0485

Award Date 7/31/24
Potential Completion Date 8/30/24
Potential Value $1.3K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,333.36, is for the delivery of Hepatitis B Vaccine (Recombinant) 10MCG to support the medical supply needs of the Department of Defense (DoD) healthcare facilities. The contract is a firm fixed-price delivery order and does not have a set-aside designation. It is part of a...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,560.32, is for the delivery of Hepatitis B virus vaccines. The contract is a Delivery Order under the SPE2D023F0455 contract vehicle and has a period of performance ending on July 27, 2023. This contract was not set aside for any specific business category. DMS Pharmaceutical...
This federal contract award, identified as SPE2D021D0004|SPE2D023F0437, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,950.40 fixed-price delivery order contract is for the provision of Hepatitis B Virus vaccines and related medical supplies, with a completion date of July 21, 2023. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA...
This is a $1,170.24 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of hepatitis B virus vaccines and has an ultimate completion date of July 27, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
The U.S. Defense Logistics Agency (DLA) awarded a $3,120.64 firm fixed-price delivery order (SPE2D023F0459) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the provision of Hepatitis B Virus vaccines and is part of a larger $499,999,999 Indefinite Delivery Contract (SPE2DB) between DMS Pharmaceutical Group and DLA, which covers a wide range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This delivery...
This federal contract award, valued at $1,772.20, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical...
This federal contract award, SPE2DP21P0338, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,779 firm fixed-price purchase order is for the delivery of Hepatitis B Virus V products. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,105.90 firm fixed-price delivery order (SPE2DP18F0330) is for the provision of hepatitis A vaccine. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,131.90 firm fixed-price delivery order is for the supply of Hepatitis A virus vaccine products. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC enables the DLA to issue...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $1,333.36, is for the provision of Hepatitis B vaccine (recombinant) 10mcg/dose to support the recurring medical supply needs of military health facilities. The contract has an ultimate completion date of April 30, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite...
  • SPE2D021D0004
    Indefinite Delivery Contract
  • SPE2D021D0004-SPE2D024F0485
    Delivery Order

This federal contract award, valued at $1,333.36, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of Hepatitis B Virus Vaccine (HBVV) products. It does not have a set-aside designation.

DMS Pharmaceutical Group Inc. is an established federal contractor, holding a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program. This IDC enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

Generated 7/11/25, 10:15 AM